What's Happening?
Community Pharmacy England (CPE) has reported a record number of 254 price concessions granted by the government in June 2026, more than double the number from the previous year. This marks the fourth consecutive month of record-high concessions, indicating
sustained pressure on the medicines pricing system. The increase in concessions is attributed to rising costs from the Middle East conflict affecting the supply chain. Olivier Picard, chair of the National Pharmacy Association, has called for government intervention to support pharmacies facing inflated medicine prices that exceed NHS reimbursement rates. The situation is creating cashflow challenges for pharmacies, impacting their ability to provide patient care.
Why It's Important?
The record number of price concessions highlights significant challenges in the UK's medicines supply chain, exacerbated by geopolitical conflicts and a 'broken' reimbursement model. Pharmacies are struggling with increased costs and cashflow issues, which could lead to shortages and impact patient care. The situation underscores the need for government action to address the pricing system's shortcomings and ensure pharmacies are adequately reimbursed. Without intervention, the sustainability of the medicines supply chain and the ability of pharmacies to deliver essential services could be at risk.
What's Next?
CPE plans to meet with government ministers to discuss community pharmacy contract reform, focusing on margin, medicine supply, and other critical issues. The outcome of these discussions could lead to changes in the reimbursement model and pricing system, potentially alleviating some of the pressures on pharmacies. However, the ongoing geopolitical tensions and their impact on the supply chain remain a concern. Stakeholders will be closely monitoring the government's response and any policy changes that may arise from these negotiations.
